Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
3.600
-0.100 (-2.70%)
At close: Apr 28, 2026, 4:00 PM EDT
3.300
-0.300 (-8.33%)
After-hours: Apr 28, 2026, 7:42 PM EDT
Turn Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Turn Therapeutics stock has a target of 8.00, which predicts an increase of 122.22% from the current stock price of 3.60.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 24, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Turn Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +122.22% | Mar 24, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +122.22% | Jan 20, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +122.22% | Dec 29, 2025 |
Financial Forecast
Revenue This Year
204.00M
Revenue Next Year
2.60M
from 204.00M
Decreased by -98.73%
EPS This Year
-0.11
from -0.12
EPS Next Year
-0.26
from -0.11
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 420.0M | 5.4M | |
| Avg | 204.0M | 2.6M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | -97.4% | |
| Avg | - | -98.7% | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.11 | -0.16 | |
| Avg | -0.11 | -0.26 | |
| Low | -0.12 | -0.35 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.